• No products in the list

MSI OncoKitDx

Short description

Microsatellite Instability Analysis with MSI OncoKitDx

MSI OncoKitDx by Health in Code is designed to provide accurate and reliable cancer diagnostics through conventional PCR and capillary electrophoresis. The kit includes a multi-marker panel of eight unique markers, featuring the Bethesda Panel recommended by the National Cancer Institute. It allows clinicians to analyze multiple markers simultaneously, enhancing diagnostic precision and facilitating individualized treatment plans.

The kit is ISO 13485:2018 certified, meeting the highest standards of quality and reliability.

Product highlights

  • Fragment Analysis
  • Genomic DNA Control
  • Fluorophore Labels
  • Multi-Tissue Compatibility


Ask for a quote

MSI OncoKitDx



Instructions for Use



For any missing information or if you require additional details, please do not hesitate to contact us. 

Specifications of the MSI OncoKitDx

MSI OncoKitDx: The Pinnacle of Microsatellite Instability Analysis

Understanding the intricacies of cancer demands a level of diagnostic accuracy that leaves no room for error. MSI OncoKitDx by Health in Code combines state-of-the-art conventional PCR and capillary electrophoresis to offer a comprehensive and reliable analysis of microsatellite instability (MSI), a pivotal marker for various cancer types.

At the core of the MSI OncoKitDx lies its multi-marker panel, designed to flawlessly detect instability in both tumoral and healthy tissue. Featuring eight markers—including the renowned Bethesda Panel recommended by the National Cancer Institute since 1997—this kit offers a diagnostic depth that’s second to none.

Just like how each cancer patient is unique, so is each tissue sample. That’s why the MSI OncoKitDx can simultaneously analyze multiple markers, giving clinicians a more holistic picture of the disease state, enhancing prognosis, and even tailoring treatment approaches. This adaptability makes it an invaluable asset in personalized medicine, guiding therapeutic decisions that are custom-fit to each patient’s unique genetic landscape.

Tailored Features for Robust Analysis
Multi-Marker Panel: 8 unique markers for comprehensive MSI analysis.
Bethesda Inclusion: 5 Bethesda Panel markers for added reliability.
Capillary Electrophoresis: Advanced detection method for refined analysis.
Multi-Tissue Compatibility: Valid for a variety of tissue types.
Amplification Range: A versatile 90-200 bp range.
Quality Control: Includes a genomic DNA control for optimal results.

We understand that in the field of cancer diagnostics, there’s no compromise on quality. That’s why the MSI OncoKitDx is ISO 13485:2018 certified, ensuring its alignment with the highest standards of quality and reliability.

Conclusion: Setting a New Standard in Cancer Care
The MSI OncoKitDx offers a new dimension in cancer diagnostics, promising a future where every diagnosis is not just accurate but also timely and comprehensive. For clinicians and laboratories seeking to push the boundaries of what’s possible in cancer care, your next breakthrough is here.

Components of the MSI OncoKitDx

The kit contents the necessary reagents to perform 48 reactions. The reagents included in the kit are the following:

  • General Master Mix III: Conventional PCR enzyme with 7.5 mM MgCl2.
  • MSI Buffer: Buffer with MgCl2.
  • MSI Master Mix: Contain the oligonucleotides needed to carry out the amplification of the
    kit’s target regions.
  • Positive Control: Genomic DNA control with normal alleles of all the region analysed

Explore Related Items